
Choroidal dysfunction plays a crucial role in retinal diseases, highlighting its potential as a therapeutic target and the need for innovative treatments.
Matt Hoffman is the editorial director for Ophthalmology Times, Modern Retina, and Ophthalmology Times Europe. He has covered medical news for MJH Life Sciences, Eye Care Network’s parent company, since 2017.

Choroidal dysfunction plays a crucial role in retinal diseases, highlighting its potential as a therapeutic target and the need for innovative treatments.